Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity

STT Schetters; RJE Li; LJW Kruijssen; S Engels; M Ambrosini; JJ Garcia-Vallejo; H Kalay; Wendy Unger; Y van Kooyk

doi:10.1016/j.biomaterials.2020.120342

Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity

STT Schetters, RJE Li, LJW Kruijssen, S Engels, M Ambrosini, JJ Garcia-Vallejo, H Kalay, Wendy Unger, Y van Kooyk

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

6 Downloads (Pure)

Original language	English
Article number	120342
Journal	Biomaterials
Volume	262
DOIs	https://doi.org/10.1016/j.biomaterials.2020.120342
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.biomaterials.2020.120342

Repub_130169_O-A.pdfFinal published version, 12.2 MB

http://hdl.handle.net/1765/130169

Cite this

@article{9a9f3ba4a4b343aaa1e05c0fdd2a8c37,

title = "Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity",

author = "STT Schetters and RJE Li and LJW Kruijssen and S Engels and M Ambrosini and JJ Garcia-Vallejo and H Kalay and Wendy Unger and {van Kooyk}, Y",

year = "2020",

doi = "10.1016/j.biomaterials.2020.120342",

language = "English",

volume = "262",

journal = "Biomaterials",

issn = "0142-9612",

publisher = "Elsevier",

}

TY - JOUR

T1 - Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity

AU - Schetters, STT

AU - Li, RJE

AU - Kruijssen, LJW

AU - Engels, S

AU - Ambrosini, M

AU - Garcia-Vallejo, JJ

AU - Kalay, H

AU - Unger, Wendy

AU - van Kooyk, Y

PY - 2020

Y1 - 2020

U2 - 10.1016/j.biomaterials.2020.120342

DO - 10.1016/j.biomaterials.2020.120342

M3 - Article

VL - 262

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

M1 - 120342

ER -